Merck & Company, Inc. · NYSE:MRK

Oosthuizen Johannes Jacobus exercised options for 1,377 Merck & Company, Inc. shares (Form 4)

Traded Apr 29, 2026 · Filed May 1, 2026

On Apr 29, 2026, Oosthuizen Johannes Jacobus (EVP, Oncology & Int?l) exercised options for 1,377 Merck & Company, Inc. shares at US$110.03 for US$152K, leaving 21,895 shares. Filed May 1, 2026 (Form 4).

Options exercised
1,377 shares
Price
US$110.03
Value
US$152K
Holding after
21,895 shares
Trading plan
No
Role
EVP, Oncology & Int?l

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 29, 2026Common StockOption exercise1,377US$110.0322,574Direct
Apr 29, 2026Common StockShares withheld for tax679US$110.0321,895Direct

Source

View original at SEC

Related